Evidence map›Paper›PMID 25836763›Full record

ReviewBone2015

Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.

Jonathan A R Gordon, Janet L Stein, Jennifer J Westendorf, Andre J van Wijnen

Abstract readReview
In one paragraph

Review in Bone, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Regulation of chromatin organization during animal regeneration.Cell regeneration (London, England) · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jonathan A R GordonDepartment of Biochemistry, University of Vermont, Burlington, VT, USA. Electronic address: Jonathan.A.Gordon@uvm.edu.
Janet L SteinDepartment of Biochemistry, University of Vermont, Burlington, VT, USA. Electronic address: Janet.Stein@uvm.edu.
Jennifer J WestendorfDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address: Westendorf.Jennifer@mayo.edu.
Andre J van WijnenDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address: vanwijnen.andre@mayo.edu.
University of Vermont · USMayo Clinic · USMayo Clinic in Arizona · US

Funding

CONTROL OF OSTEOBLAST PROLIFERATION AND DIFFERENTIATIONR01AR039588 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B., STEIN, GARY S. · 1990 to 2019
$8.0M
Molecular Control of Bone FormationR01AR049069 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WESTENDORF, JENNIFER J · 2003 to 2021
$5.8M
Synthesis of Osteocalcin in BoneR37DE012528 · NIDCR · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B. · 2008 to 2017
$5.0M
SYNTHESIS OF OSTEOCALCIN IN BONER01DE012528 · NIDCR · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B · 1997 to 2006
$2.6M
Runx2 and Axin2 Interactions During Bone FormationR01DE020194 · NIDCR · MAYO CLINIC ROCHESTER · PI WESTENDORF, JENNIFER J · 2010 to 2014
$2.1M
Protein Phosphatase Phlpp1 in Cartilage Development & Osteoarthritis ProgressionR01AR068103 · NIAMS · MAYO CLINIC ROCHESTER · PI WESTENDORF, JENNIFER J · 2014 to 2018
$1.9M
Phlpp protein phosphatases in cartilage development and diseaseR56AR068103 · NIAMS · MAYO CLINIC ROCHESTER · PI WESTENDORF, JENNIFER J · 2019 to 2019
$552k
Synthesis of Osteocalcin in BoneR56DE012528 · NIDCR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI LIAN, JANE B., STEIN, GARY S. · 2018 to 2018
$427k
NIAMS NIH HHS AR039588NIAMS NIH HHS AR049069NIAMS NIH HHS AR68103NIAMS NIH HHS R01 AR039588NIAMS NIH HHS R01 AR049069NIAMS NIH HHS R01 AR068103NIAMS NIH HHS R56 AR068103NIDCR NIH HHS DE012528NIDCR NIH HHS DE20194NIDCR NIH HHS R01 DE012528NIDCR NIH HHS R01 DE020194NIDCR NIH HHS R37 DE012528NIDCR NIH HHS R56 DE012528
6 · The paper itself

Abstract

Post-translational modifications of chromatin such as DNA methylation and different types of histone acetylation, methylation and phosphorylation are well-appreciated epigenetic mechanisms that confer information to progeny cells during lineage commitment. These distinct epigenetic modifications have defined roles in bone, development, tissue regeneration, cell commitment and differentiation, as well as disease etiologies. In this review, we discuss the role of these chromatin modifications and the enzymes regulating these marks (methyltransferases, demethylases, acetyltransferases, and deacetylases) in progenitor cells, osteoblasts and bone-related cells. In addition, the clinical relevance of deregulated histone modifications and enzymes as well as current and potential therapeutic interventions targeting chromatin modifiers are addressed.

Indexed as

AcetylationAnimalsBone DevelopmentBone DiseasesBone RegenerationChromatinDNA MethylationEpigenesis, GeneticHistone CodeHistone Deacetylase InhibitorsHumansMiceProtein Processing, Post-TranslationalChromatinHistone Deacetylase InhibitorsAcetylationChromatinChromatin-modifiersEpigeneticsMethylationOsteogenic lineage cells

Identifiers

PMID25836763
PMCPMC4591092
OpenAlexW2012373502

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.